First Regular Session | 72nd General Assembly
Colorado General AssemblyThis issue brief provides an overview of federal and state family and medical leave laws, including an overview of state paid family leave programs.
The Opioid and Other Substance Use Disorders Study Committee was created pursuant to Article 22.3 of Title 10, Colorado Revised Statutes. The purpose of this committee is to study issues relating to opioid and substance use disorders in Colorado and examine potential solutions concerning...
The Colorado Health Insurance Exchange Oversight Committee was created pursuant to Article 22 of Title 10, Colorado Revised Statutes. The purpose of this committee is to guide Colorado's health insurance exchange, including reviewing the financial and operational plans of the exchange and...
This issue brief addresses Colorado’s emergency mental health hold procedure, which allows for an individual to be involuntarily held for a 72‑hour period of treatment and evaluation if he or she appears to have a mental illness and, due to the mental illness, appears to be an imminent...
During the 2018 legislative session, the General Assembly considered a number of measures related to Medicaid, insurance carriers, and health care facilities. It also considered measures concerning substance use disorders, health care costs, and the health care workforce.
During the 2018 legislative session, the General Assembly considered measures related to increasing access to behavioral health services, increasing capacity for competency restoration, protecting children in foster care, child care assistance funding, and increasing the effectiveness of other...
The Colorado Health Insurance Exchange Oversight Committee was created pursuant to Article 22 of Title 10, Colorado Revised Statutes. The purpose of this committee is to guide Colorado's health insurance exchange, including reviewing the financial and operational plans of the exchange and...
Final Report to the Colorado General Assembly by the Legislative Oversight Committee Concerning the Treatment of Persons with Mental Health Disorders in the Criminal and Juvenile Justice Systems.
Final Report to the Colorado General Assembly by the Opioid and Other Substance Use Disorders Interim Study Committee.
Presented to the TLRC at its November 2, 2017 meeting.
This memorandum addresses patient access to experimental treatments, including access to clinical trials, participation in the U.S. Food and Drug Administration’s Expanded Access (Compassionate Use) Program, and access to treatments under Colorado’s Right to Try Act. Additionally, this...
This issue brief explains Colorado’s Temporary Assistance for Needy Families (TANF) program, known as Colorado Works, which provides financial and other assistance. The federally funded program is overseen at the state level by the Department of Human Services and is administered at the county...
This issue brief addresses the state’s emergency mental health hold procedure, which allows for a person to be involuntarily held for a 72-hour period of treatment and evaluation if he or she appears to have a mental illness and, due to the mental illness, appears to be an imminent danger to...
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its September 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its September 2017 meeting.
Presented to the Opioid and Other Substance Use Disorder Interim Study Committee at its September 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its September 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its September 2017 meeting.
Presented to the Opioid and Other Substance use Disorders Interim Study Committee at its September 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its September 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its September 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its September 2017 meeting.